A Phase 2 Study of Botensilimab, Balstilimab and Regorafenib in Patients With Microsatellite Stable Colorectal Cancer
Latest Information Update: 03 Sep 2024
At a glance
- Drugs Balstilimab (Primary) ; Botensilimab (Primary) ; Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Sep 2024 New trial record